Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Discover various ways to sell products for cash at home. Turn your unused items into quick cash and declutter your space.
22,710 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A fresh, data-driven look at how tariffs reshape markets and wallets. This piece presents a practical approach for re...
Goldman Sachs moves to remove DEI requirements for its board as conservative pressure grows. The move signals a wider...
Caterpillar—a 100-year-old icon in heavy equipment—is redefining its path by embracing AI-enabled infrastructure, dat...
As markets navigate early-2026 volatility, three dividend-focused ETFs stand out for beginners. Low fees, broad diver...
Hungary blocks a massive EU loan to Ukraine, tying funding to the restart of Druzhba pipeline oil flows after a disru...
New Delhi hosted a five-day AI summit that culminated in the New Delhi Declaration and a $200 billion investment pled...
A leading economist argues that the stock market has drifted away from the pace of everyday economic activity as grow...
Large holders have added 820,000,000 ADA in six months, trimming circulating supply and fueling a potential ADA recov...
A U.S. equity ETF with about $11 billion in assets is beating the broad market by favoring profitable, attractively v...
A look at WWII-era weapons that helped allies reveals how innovation and mass production built a durable defense base...
Global markets react to a sharp escalation in the Iran crisis after U.S.-Israel strikes. A former Trump security advi...